Golidocitinib can produce lasting responses in patients with relapsed or refractory PTCL, according to a new study. Golidocitinib can produce lasting responses in patients with relapsed or refractory PTCL, according to a new study.
Relmacabtagene autoleucel continued to induce responses with acceptable tolerability in Chinese patients with relapsed or refractory mantle cell lymphoma.
This year marks the 10th anniversary of Chinese President Xi Jinping’s proposal to build a community with a shared future for mankind, the principles guiding China’s Africa policy, including sincerity, real results, amity and good faith and the Belt and Road Initiative (BRI).
BRI brings China, Nigeria win-win results vanguardngr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vanguardngr.com Daily Mail and Mail on Sunday newspapers.